Cytokinetics Announces Primary Results from MAPLE-HCM Presented at the European Society of Cardiology Congress 2025 and Published in The New England Journal Of Medicine
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint…
Delska’s New 10MW Data Center in Latvia Achieves Tier III Design Certification
RIGA, Latvia, Aug. 19, 2025 /PRNewswire/ -- Northern European data center operator Delska's upcoming…
Bybit EU Taps XION for Inaugural Launchpool in the EU, Opening Regulated Access for 450M+ Users
First-ever Launchpool on Bybit's EU newly MiCAR-licensed EU exchange, going live on 14th…
NEXEN TIRE Selected as Original Equipment Supplier for Citron C5/C5 Aircross by Stellantis
Kelkheim, August 11, 2025 — Nexen Tire, a leading global tire manufacturer,…
GENESIS MOTOR EUROPE APPOINTS PETER KRONSCHNABL AS NEW MANAGING DIRECTOR
Peter Kronschnabl joins Genesis Motor Europe as Managing DirectorAppointment supports Genesis’ strategic…
Fermenta Announces Granting of CEP by EDQM for VITADEE 100 SD, Enabling Accelerated Global Growth
THANE, India, July 30, 2025 /PRNewswire/ -- Fermenta Biotech Limited ("Fermenta"), a pioneer…
Kyowa Kirin Announces Abstract Presentation at the European Academy of Dermatology and Venereology (EADV) Congress
PRINCETON, N.J. and TOKYO, July 29, 2025 /PRNewswire/ -- Kyowa Kirin Co.,…
Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure
ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II…
Almirall H1 2025 Results
Almirall Continues to Deliver on its Long-Term Growth Strategy with Net Sales…
AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS
PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO…